Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Orthomod LLC currently manages 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are split between 2 distinct examiners and 2 distinct art units. This indicates that each of the company's pending matters is being reviewed by a different examiner in a different specialized group at the USPTO.
The busiest examiner, MEYERS, ELIZABETH ANNE, holds 1 pending office action. With 2 distinct examiners each responsible for one of the 2 pending office actions, the workload is evenly distributed. The use of 2 distinct art units within the Biotechnology & Pharmaceuticals area suggests that the technologies involved may require different specialized knowledge for successful prosecution. Practitioners should tailor their arguments to the specific expectations of each of the 2 distinct examiners, as the lack of overlap in art units means that procedural norms may vary between the two pending cases.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MEYERS, ELIZABETH ANNE | 1 | 22.2% | +93.3% |
| SPENCER, MAXIMILIAN TOBIAS | 1 | 34.3% | +32.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18974495 | CROSSLINKED STRUCTURAL ORTHOPEDIC BIOMATERIAL AND METHOD FOR MANUFACTURE | MEYERS, ELIZABETH ANNE | — |
| 18778077 | ISOTROPIC SURGICAL IMPLANTS WITH FLOW-DEPOSITED CERAMIC PARTICLES | SPENCER, MAXIMILIAN TOBIAS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18974495 | CROSSLINKED STRUCTURAL ORTHOPEDIC BIOMATERIAL AND METHOD FOR MANUFACTURE | MEYERS, ELIZABETH ANNE | — |
| 18778077 | ISOTROPIC SURGICAL IMPLANTS WITH FLOW-DEPOSITED CERAMIC PARTICLES | SPENCER, MAXIMILIAN TOBIAS | — |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| 3774 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18974495 | CROSSLINKED STRUCTURAL ORTHOPEDIC BIOMATERIAL AND METHOD FOR MANUFACTURE | MEYERS, ELIZABETH ANNE | 1617 | §103§112 | Non-Final OA | — | Pending | Dec 09, 2024 |
| 18778077 | ISOTROPIC SURGICAL IMPLANTS WITH FLOW-DEPOSITED CERAMIC PARTICLES | SPENCER, MAXIMILIAN TOBIAS | 3774 | §102§103 | Non-Final OA | — | Pending | Jul 19, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOrthomod LLC has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Elizabeth Anne Meyers has the most, with 1 of Orthomod LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
